✦ LIBER ✦

Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay

✍ Scribed by C. Kent Osborne; Daniel D. Von Hoff; Kathryn Mullins

Publisher: Springer US
Year: 1985
Tongue: English
Weight: 670 KB
Volume: 6
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01806773

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative studies of chemotherapy of h

Comparative studies of chemotherapy of human tumor cells in vitro by tritiated thymidine uptake inhibition and soft agar clonogenic assay

✍ Karimullah A. Zirvi; George J. Hill; Helene Z. Hill 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

Current role of endocrine therapy in the

Current role of endocrine therapy in the management of breast cancer

✍ John F. R. Robertson 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 608 KB

Histochemical assay of estrogen and prog

Histochemical assay of estrogen and progesterone receptors in breast cancer: Correlation with biochemical assays and patients' response to endocrine therapies

✍ Louis P. Pertschuk; Ellis H. Tobin; Eric Gaetjens; Anne C. Carter; George A. Deg 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 697 KB

Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand-conjugates composed of 17P-estradiol and 1 lcu-hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescein isothiocyanate were emp

Estrogen and progesterone receptors in t

Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

✍ Andrea Manni; Baha'Uddin Arafah; Olof H. Pearson 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to

Prediction of response to endocrine ther

Prediction of response to endocrine therapy in breast cancer using immunocytochemical assays for pS2, oestrogen receptor and progesterone receptor

✍ Y. A. Luqmani; D. Ricketts; G. Ryall; L. Turnbull; M. Law; R. C. Coombes 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 802 KB

Histological sections obtained from 70 patients with breast cancer, all of whom had received endocrine therapy for metastatic or locally advanced disease, were assessed for specific immunocytochemical staining of oestrogen receptor and the oestrogen-induced protein pS2. There was also sufficient mat

The role of mammography in the evaluatio

The role of mammography in the evaluation of advanced breast cancer treated by initial endocrine therapy

✍ P. Sauven; R. Grant; I. Burn 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

## Abstract Fifty-five patients with locally advanced breast cancer treated with initial endocrine therapy have been followed up for periods of between 6 and 64 months (median 17 months) with regular clinical and radiological examination. The aim of the study was to evaluate the role of mammography